Epidemiology and screening for prostate cancer.
This activity is designed for primary care physicians, internists, and general audiences.


OBJECTIVE
To provide the reader with a basic understanding of the controversy surrounding population-based prostate cancer screening and of the tools needed to conduct early detection programs for prostate cancer among enrollees.


OBJECTIVE
1. Become familiar with the national debate regarding population-based prostate cancer screening. 2. Learn the essential elements of prostate specific antigen testing for patients. 3. Understand the cost-effectiveness and medico-legal/informed consent issues surrounding prostate cancer detection and screening.
Moul
J W
JW
Urology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA. ltc_judd_moul@wramc1-amedd.army.mil
D000328:Adult; D000367:Age Factors; D000368:Aged; D002983:Clinical Competence / Q000592:standards; D003362:Cost-Benefit Analysis; D004502:Education, Medical, Continuing; D006801:Humans; D007258:Informed Consent; D007388:Internal Medicine; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000592:standards*; D008875:Middle Aged; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology